Share-based Payment Arrangement, Expense in USD of Astrana Health, Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Astrana Health, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from 2011 to Q3 2025.
  • Astrana Health, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $7,700,000, a 24.2% increase year-over-year.
  • Astrana Health, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $42,418,000, a 51.4% increase year-over-year.
  • Astrana Health, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $34,536,000, a 56.7% increase from 2023.
  • Astrana Health, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $22,040,000, a 36.9% increase from 2022.
  • Astrana Health, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16,101,000, a 139% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Astrana Health, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $42,418,000 $7,700,000 +$1,500,000 +24.2% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $40,918,000 $11,709,000 +$4,319,000 +58.4% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $36,599,000 $7,811,000 +$2,063,000 +35.9% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $34,536,000 $15,198,000 +$6,522,000 +75.2% 01 Oct 2024 31 Dec 2024 10-K 14 Mar 2025 2024 FY
Q3 2024 $28,014,000 $6,200,000 +$494,000 +8.66% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $27,520,000 $7,390,000 +$3,177,000 +75.4% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $24,343,000 $5,748,000 +$2,303,000 +66.9% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $22,040,000 $8,676,000 +$3,052,000 +54.3% 01 Oct 2023 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $18,988,000 $5,706,000 +$2,204,000 +62.9% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $16,784,000 $4,213,000 +$293,000 +7.47% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $16,491,000 $3,445,000 +$390,000 +12.8% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $16,101,000 $5,624,000 +$3,201,000 +132% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2025 2024 FY
Q3 2022 $12,900,000 $3,502,000 +$2,082,000 +147% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $10,818,000 $3,920,000 +$2,364,000 +152% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $8,454,000 $3,055,000 +$1,709,000 +127% 01 Jan 2022 31 Mar 2022 10-Q/A 09 Aug 2023 2023 Q1
Q4 2021 $6,745,000 $2,423,000 +$1,598,000 +194% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $5,147,000 $1,420,000 +$772,000 +119% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $4,375,000 $1,556,000 +$704,000 +82.6% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $3,671,000 $1,346,000 +$288,000 +27.2% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $3,383,000 $825,000 01 Oct 2020 31 Dec 2020 10-K/A 09 Aug 2023 2022 FY
Q3 2020 $648,000 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $852,000 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $1,058,000 +$712,866 +207% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $953,190 $345,134 -$488,810 -58.6% 01 Jan 2019 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $1,442,000 $203,292 -$946,125 -82.3% 01 Oct 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
Q3 2018 $2,388,125 $202,382 -$118,851 -37% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $2,506,976 $202,382 -$118,851 -37% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $2,625,827 $833,944 +$512,711 +160% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $2,113,116 $1,149,417 +$798,902 +228% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $1,314,214 $321,233 +$75,192 +30.6% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,239,022 $321,233 +$73,516 +29.7% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $1,165,506 $321,233 -$603,502 -65.3% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $1,769,008 $350,515 +$324,008 +1222% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2017 2017 Q3
Q3 2016 $1,445,000 $246,041 +$177,155 +257% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2018 Q2
Q2 2016 $1,267,845 $247,717 +$163,869 +195% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2018 Q1
Q1 2016 $1,103,976 $924,735 +$798,097 +630% 01 Jan 2016 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 $305,879 $26,507 -$130,045 -83.1% 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017 2017 Q3
Q3 2015 $435,924 $68,886 -$787,633 -92% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2017 Q2
Q2 2015 $1,223,557 $83,848 -$35,291 -29.6% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2017 Q1
Q1 2015 $1,258,848 $126,638 +$66,451 +110% 01 Jan 2015 31 Mar 2015 10-K 29 Jun 2016 2016 FY
Q4 2014 $1,192,397 $156,552 +$178,756 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016 2016 Q3
Q3 2014 $1,013,641 $856,519 +$287,811 +50.6% 01 Jul 2014 30 Sep 2014 10-Q 17 Nov 2015 2016 Q2
Q2 2014 $725,830 $119,139 -$1,433,165 -92.3% 01 Apr 2014 30 Jun 2014 10-Q 28 Aug 2015 2016 Q1
Q1 2014 $2,158,995 $60,187 +$14,901 +32.9% 01 Feb 2014 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q4 2013 $2,144,094 $-22,204 -$351,631 -107% 01 Oct 2013 31 Dec 2013 10-Q 23 Feb 2015 2015 Q3
Q3 2013 $2,495,725 $568,708 -$978,529 -63.2% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q2
Q2 2013 $3,474,254 $1,552,304 +$1,471,374 +1818% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2015 Q1
Q1 2013 $2,002,880 $45,286 -$58,848 -56.5% 01 Feb 2013 31 Mar 2013 10-QT 08 Jul 2014 2015 Q1
Q4 2012 $2,061,728 $329,427 01 Nov 2012 31 Jan 2013 10-K 08 May 2014 2013 FY
Q3 2012 $1,547,237 01 Aug 2012 31 Oct 2012 10-Q 20 Dec 2013 2013 Q3
Q2 2012 $80,930 01 May 2012 31 Jul 2012 10-Q 16 Sep 2013 2013 Q2
Q1 2012 $104,134 01 Feb 2012 30 Apr 2012 10-Q 14 Jun 2013 2013 Q1

Astrana Health, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $34,536,000 +$12,496,000 +56.7% 01 Jan 2024 31 Dec 2024 10-K 14 Mar 2025 2024 FY
2023 $22,040,000 +$5,939,000 +36.9% 01 Jan 2023 31 Dec 2023 10-K 14 Mar 2025 2024 FY
2022 $16,101,000 +$9,356,000 +139% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2025 2024 FY
2021 $6,745,000 +$3,362,000 +99.4% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $3,383,000 +$1,836,000 +119% 01 Jan 2020 31 Dec 2020 10-K/A 09 Aug 2023 2022 FY
2019 $1,547,000 +$105,000 +7.28% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,442,000 -$671,116 -31.8% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
2017 $2,113,116 +$158,878 +8.13% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $1,954,238 +$850,262 +77% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $1,103,976 -$154,872 -12.3% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017 2017 FY
2014 $1,258,848 -$899,009 -41.7% 01 Apr 2014 31 Mar 2015 10-K 29 Jun 2016 2016 FY
2013 $2,157,857 +$96,129 +4.66% 01 Feb 2013 31 Jan 2014 10-K 14 Jul 2015 2015 FY
2012 $2,061,728 +$1,879,995 +1034% 01 Feb 2012 31 Jan 2013 10-K 08 May 2014 2013 FY
2011 $181,733 01 Feb 2011 31 Jan 2012 10-K 01 May 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.